GO
Loading...

Analyst Interviews

Stifel analyst: Time to buy Target   Mon, 10 Nov '14 | 12:45 PM ET
Stifel analyst: Time to buy Target

After two years with a hold rating on Target, Stifel Nicolaus has upgraded the stock to a buy rating. David Schick, Stifel Nicolaus, provides insight to the firm's move.

$BABA 'Singles Day'

Discussing how investors should play Alibaba's "Singles' Day," and what other retailers will benefit, with Robert Peck, SunTrust analyst.

Where McDonald's is making progress   Mon, 10 Nov '14 | 10:10 AM ET
Where McDonald's is making progress

Discussing McDonald's sales slump and where the fast food chain is making gains, with Stephen Anderson, Miller Tabak senior analyst.

Disney bull case 2 years out: Analyst   Fri, 7 Nov '14 | 10:45 AM ET
Disney bull case 2 years out: Analyst

Discussing Disney's quarterly results amid recent concerns of soft advertising revenue growth, with Vasily Karasyov, Sterne Agee senior analyst.

Analyst downgrades Twitter to 'neutral'   Fri, 7 Nov '14 | 7:34 AM ET
Analyst downgrades Twitter to 'neutral'

Anthony DiClemente, Nomura Securities analyst, provides perspective on the social media company as it celebrates its first anniversary as a public company.

Elon Musk: Demand not our issue, production is

After Tesla's earnings beat, the stock is higher. On the call, CEO Elon Musk said "demand is not our issue, production is." Ben Kallo, R.W. Baird analyst, provides perspective.

Tesla stock grossly overvalued: Pro   Wed, 5 Nov '14 | 4:18 PM ET
Tesla stock grossly overvalued: Pro

Carter Driscoll, MLV and Company, and John Thompson, Vilas Capital CEO, provide instant analysis into Tesla's quarterly numbers. The company beat EPS and revenue estimates.

Intel: Analyst says time to sell   Wed, 5 Nov '14 | 12:54 PM ET
Intel: Analyst says time to sell

Stacy Rasgon, AllianceBernstein senior analyst, explains his concerns for Intel.

Tesla long-term strategic play: Pro   Wed, 5 Nov '14 | 6:31 AM ET
Tesla long-term strategic play: Pro

George Galliers, ISI Group auto analyst, provides a preview of Tesla's quarterly results and shares his thoughts on the automakers direct-sell model.

Virgin crash: What did they overlook?

After Virgin Galactic's SpaceShipTwo crashed, James Oberg, NBC space analyst, says the first step of investigators should be to create a timeline of events.

Street Talk: IMPV, COTY & more   Fri, 31 Oct '14 | 2:35 PM ET
Street Talk: IMPV, COTY & more

"Street Signs" hosts Mandy Drury and Brian Sullivan look at 5 stocks with analyst recommendations, including and upgrade for Coty an downgrade for Avon.

Big bull on GoPro   Fri, 31 Oct '14 | 12:15 PM ET
Big bull on GoPro

Shares of GoPro surge after better-than-expected earnings. Big GoPro bull Alex Guana, JMP Securities analyst, has no concerns about GoPro.

Exxon beats, Chevron mixed

Both Chevron and Exxon have beat on earnings, but are lowering production. Pavel Molchanov, Raymond James energy analyst, discusses whether these stocks are oversold.

Buy XOM on beat? Not really says pro   Fri, 31 Oct '14 | 8:17 AM ET
Buy XOM on beat? Not really says pro

Fadel Gheit, Oppenheimer & Company energy analyst, provides insight on big energy's Exxon Mobile and Chevron.

Citi's legal woes cuts into profits   Fri, 31 Oct '14 | 7:19 AM ET
Citi's legal woes cuts into profits

We knew FX was coming but it doesn't change my outlook at all, says, Jeff Harte, Sandler O'Neil, discussing the impact of the $600 million legal charge on earnings.

Why GoPro's holiday picture looks sharp   Fri, 31 Oct '14 | 6:38 AM ET
GoPro after-hours hero, crushes expectations

Charlie Anderson, Dougherty & Company analyst, breaks down the company's quarterly numbers and weighs in on GoPro's valuation and prospects as a media company.

Starbucks delivers a jolt   Fri, 31 Oct '14 | 6:25 AM ET
Starbucks delivers a jolt

Shares of the coffee retailer dropped after reporting a big miss on sales, but it plans to launch a food and delivery service in select markets during the second half of 2015. David Palmer, RBC Capital Markets, shares his thoughts on the company's outlook.

Citi's forex pain prompts profit cuts   Fri, 31 Oct '14 | 6:10 AM ET
Citi's forex pain prompts profit cuts

Marty Mosby, Vining Sparks analyst, discusses whether there is likely to be any long-term impact on the big bank due to its legal woes. Also Mosby explains why he is optimistic about Citigroup going forward.

Legal woes trim Citi's earnings   Fri, 31 Oct '14 | 6:08 AM ET
Legal woes trim Citi's earnings

CNBC's Kayla Tausche, reports the big bank cut back $600 million in profits due to increased legal costs.

Buy Facebook's dip? Mahaney says yes   Wed, 29 Oct '14 | 10:19 AM ET

RBC Capital Markets' Mark Mahaney thinks Facebook isn't investing enough.

Facebook announces spending plan   Wed, 29 Oct '14 | 7:18 AM ET
Facebook announces spending plan

Gene Munster, Piper Jaffray senior analyst, shares his thoughts on Facebook's mobile advertising strategy and plans to monetize WhatsApp.

Facebook should spend money: Pro   Wed, 29 Oct '14 | 6:06 AM ET
Facebook should spend money: Pro

CNBC's Jon Fortt, and Ronald Josey, JMP Securities senior analyst, discuss Facebook's quarterly numbers and its ability to monetize advertising. Also Facebook's potential to generate revenue with WhatsApp.

Social tech picks: Twitter or Facebook?   Mon, 27 Oct '14 | 10:21 AM ET
Social tech picks: Twitter or Facebook?

Twitter, Facebook and LinkedIn are set to report earnings this week. Mark Mahaney, RBC Capital Markets analyst, discusses the best bet on social, and risks associated with Twitter.

Hey Amazon, where's the profit?   Fri, 24 Oct '14 | 6:20 AM ET
Hey Amazon, where's the profit?

We've seen some "misdirected" spending, says Scott Tilghman, B. Riley & Company analyst, discussing Amazon's earnings miss and Jeff Bezo's spending strategy.

CAT analyst remains neutral   Thu, 23 Oct '14 | 10:06 AM ET
CAT analyst remains neutral

Ann Duignan, JPMorgan, gives kudos to Caterpillar, after the company reported a strong quarter. Duignan remains neutral on the stock.

Value in biotech: Pro   Wed, 22 Oct '14 | 12:14 PM ET
Value in biotech: Pro

Two biotech picks, with Yaron Werber, Citigroup biotech analyst.

Coke's long road to profits   Tue, 21 Oct '14 | 10:31 AM ET
KO's long road to profits

Discussing Coca-Cola's disappointing earnings and revenue miss, with Caroline Levy, CLSA beverage analyst.

Verizon reports mixed results   Tue, 21 Oct '14 | 8:17 AM ET
Verizon reports mixed results

Mike McCormack, Jefferies equity analyst, digs into the telcom giant's quarterly numbers and its growth outlook. Cable companies are having great success in taking revenue away in the small business market, says McCormack.

Apple's a cheap stock: Expert   Tue, 21 Oct '14 | 8:09 AM ET
Apple's a cheap stock: Expert

UBS' Steve Milunovich shares his thoughts on Apple's outlook after a blow-out quarter. The wearables could become a large category, says Milunovich.

IBM's road back   Tue, 21 Oct '14 | 8:06 AM ET
IBM's road back

UBS' Steve Milunovich weighs in on IBM's bruising quarter. Clearly IBM is in a major transition that will take multi-years to figure out, say Milunovich.

Contact Analyst Interviews

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

CEO Interviews